Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery DiseasePamela S. Douglas, Jane Cao, David Buck et al.|JAMA Cardiology|2023Cited by 97
Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 DiabetesMichelle D. Kelsey, Neha J. Pagidipati, Christopher B. Granger et al.|Journal of the American College of Cardiology|2022Cited by 95
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J. Nelson, Christopher B. Granger, Rodica Pop‐Busui et al.|JAMA Network Open|2022Cited by 73